ASAmneet Sandhu

Amneet Sandhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amneet Sandhu has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals

    by Amneet Sandhu, Haikun Bao, Karl E. Minges, Paul D. Varosy, Ryan T. Borne, Mathew M. Zipse, Lucas Marzec, Pamela Peterson, Frederick Masoudi, Steven M. Bradley

    In select patients, cardiac resynchronization therapy (CRT) is an important therapeutic option that provides significant morbidity and mortality benefits. Meta-analyses and randomized clinical trials evaluating CRT have shown improvement in heart failure–related hospitalizations, mortality, and multiple quality of life measures.1-4 As such, rates of CRT implantation in the United States have increased substantially.5,6 However, benefits of CRT are greatest among patients with left bundle branch block (LBBB) and QRS width greater than 150 milliseconds in normal sinus rhythm, as outlined in the 2012 American College of Cardiology/American Heart Association/Heart Rhythm Society (ACC/AHA/HRS) update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities.7


  • Open Access

    Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program

    by Amneet Sandhu, Maggie A. Stanislawski, Gary K. Grunwald, Kathryn Guinn, Javier Valle, Daniel Matlock, P. Michael Ho, Thomas M. Maddox, Steven M. Bradley

    Background: Little is known about facility‐level variation in the use of revascularization procedures for the management of stable obstructive coronary artery disease. Furthermore, it is unknown if variation in the use of coronary revascularization is associated with use of other cardiovascular procedures. Methods and Results: We evaluated all elective coronary angiograms performed in the Veterans Affairs system between September 1, 2007, and December 31, 2011, using the Clinical Assessment and Reporting Tool and identified patients with obstructive coronary artery disease. Patients were considered managed with revascularization if they received percutaneous coronary intervention (PCI) or coronary artery bypass grafting within 30 days of diagnosis. We calculated risk‐adjusted facility‐level rates of overall revascularization, PCI , and coronary artery bypass grafting. In addition, we determined the association between facility‐level rates of revascularization and post‐ PCI stress testing. Among 15 650 patients at 51 Veterans Affairs sites who met inclusion criteria, the median rate of revascularization was 59.6% (interquartile range, 55.7%–66.7%). Across all facilities, risk‐adjusted rates of overall revascularization varied from 41.5% to 88.1%, rate of PCI varied from 23.2% to 80.6%, and rate of coronary artery bypass graftingvariedfrom 7.5% to 36.5%. Of 6179 patients who underwent elective PCI , the median rate of stress testing in the 2 years after PCI was 33.7% (interquartile range, 30.7%–47.1%). There was no evidence of correlation between facility‐level rate of revascularization and follow‐up stress testing. Conclusions: Within the Veterans Affairs system, we observed large facility‐level variation in rates of revascularization for obstructive coronary artery disease, with variation driven primarily by PCI . There was no association between facility‐level use of revascularization and follow‐up stress testing, suggesting use rates are specific to a particular procedure and not a marker of overall facility‐level use.


  • IMPLICATIONS OF THE DUAL-ANTIPLATELET THERAPY (DAPT) TRIAL IN THE REAL WORLD: INSIGHTS FROM THE NCDR RESEARCH TO PRACTICE INITIATIVE

    by Amneet Sandhu, Patrick Stewart, Steven Bradley, Robert Yeh, John Messenger, James de Lemos, Michael Ho, Javier Valle, Gregory Hess, John Rumsfeld, et al.

  • Use of Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention

    by Amneet Sandhu, Lisa A. McCoy, Smita I. Negi, Irfan Hameed, Prashant Atri, Subhi J. Al’aRef, Jeptha Curtis, Ed McNulty, H. Vernon Anderson, Adhir Shroff, et al.

    Background—: Little is known about the contemporary use of intra-aortic balloon pump (IABP) and other mechanical circulatory support (O-MCS) devices in patients undergoing percutaneous coronary intervention (PCI) in the setting of cardiogenic shock. Methods and Results—: We identified 76 474 patients who underwent PCI in the setting of cardiogenic shock at one of 1429 National Cardiovascular Data Registry CathPCI participating hospitals from 2009 to 2013. Temporal trends and hospital-level variation in the use of IABP and O-MCS were evaluated. No mechanical circulatory support was used in 41 286 (54%) patients, 29 730 (39%) received IABP only, 2711 (3.5%) received O-MCS only, and 2747 (3.6%) received both IABP and O-MCS. At the start of the study period, 45% of patients undergoing PCI in the setting of cardiogenic shock received an IABP and 6.7% received O-MCS. The proportion of patients receiving IABP declined at an average rate of 0.3% per quarter, whereas the rate of O-MCS use was unchanged over the study period. The predicted probability of IABP use varied significantly by site (hospital median 42%, interquartile range 33% to 51%, range 8% to 85%). The probability of O-MCS use was 20% in less than one-tenth of hospitals. Conclusions—: In this large national registry, the use of IABP in the setting of PCI for cardiogenic shock decreased over time without a concurrent increase in O-MCS use. The probability of IABP and O-MCS use varied across hospitals, and the use of O-MCS was clustered at a small number of hospitals.


  • Recidivism to uncontrolled blood pressure in patients with previously controlled hypertension

    by Amneet Sandhu, P. Michael Ho, Steve Asche, David J. Magid, Karen L. Margolis, JoAnn Sperl-Hillen, Bill Rush, David W. Price, Heidi Ekstrom, Heather Tavel, et al.